Healthtech Startups

TwoStep Therapeutics is a Stanford spinout developing targeted cancer therapies, including peptide-based drug conjugates and radioligand programs built on a tumor-targeting peptide platform. The company is advancing a preclinical pipeline toward a first clinical trial planned for the second half of 2026.

4 investors

Ultima Genomics develops genomic sequencing technology to scale omics information for advances in biology and human health improvements.

4 investors

Valar Labs develops AI-powered pathology analysis tools to assist physicians in cancer treatment decisions. The company serves hospitals, clinics, and oncology practices by leveraging artificial intelligence to extract diagnostic insights from pathology slides.

4 investors

Valeo Health is an AI-driven health-tech company that delivers at-home healthcare and wellness services, including blood tests, IV drips, physiotherapy, doctor-on-call visits, weight loss and peptide therapy programs, and babysitting, with results and tracking via its app. Founded in 2021, it operates as a personalized health and wellness marketplace serving individuals in Saudi Arabia (KSA) and the UAE.

4 investors

Valo Health applies technology and data to drug discovery, working across the technology, biotech, and healthcare fields. It positions itself as a company focused on reshaping how new drugs are discovered.

4 investors

Vascular Graft Solutions develops medical device technologies for coronary revascularization procedures, with a focus on addressing vein graft disease in cardiac bypass surgery. The company serves cardiac surgeons and healthcare systems seeking to improve patient outcomes and reduce complications in heart surgery.

4 investors

VaxCare operates a platform that automates procurement, inventory management, patient eligibility, charting, and billing for vaccines and contraceptives at medical practices. It serves health systems, pediatric, family medicine, OB-GYN, and internal medicine practices, connecting suppliers, EHRs, and payers to keep practices stocked with ACIP-recommended vaccines and contraceptives.

4 investors

Vectorious Medical Technologies develops implantable sensing platforms designed to deliver clinical information for patient therapies. The company focuses on scalable, sensor-based medical devices for healthcare applications.

4 investors

Vedanta Biosciences is a clinical-stage biotech developing Live Biotherapeutic Products (LBP) based on defined consortia of bacteria to treat serious gastrointestinal diseases, with an initial focus on preventing recurrent Clostridium difficile infection. Its oral therapies target gut dysbiosis-driven conditions.

4 investors

Velorium develops transformational medicines by combining scientific research with patient-focused collaboration. The company operates in the medical research and therapeutic development space.

4 investors

Vena Vitals develops a noninvasive, continuous blood pressure monitoring device using patented sensor technology placed on the skin over an artery. The system targets anesthesiologists, sleep physicians, and hospitals for intraoperative, sleep disorder, and clinical monitoring applications.

4 investors

Veracity develops metabolic health products designed to address underlying causes of low energy, weight management issues, and cognitive symptoms. The company serves consumers seeking science-backed nutritional solutions aligned with their biological functioning.

4 investors

Veradermics is developing VDPHL01, an extended-release oral minoxidil tablet intended as a non-hormonal prescription treatment for pattern hair loss in women and men. The therapy is being evaluated in Phase 2 and Phase 3 clinical trials.

4 investors

Vera Health is a healthcare AI company advised by emergency medicine and clinical physicians from institutions such as Harvard, Columbia, and Mayo Clinic. The about page lists its medical and clinical advisory board rather than describing the product in detail.

4 investors

Verifiable provides an AI-powered platform for healthcare credentialing and provider network management that combines autonomous agents with regulatory compliance. The platform automates credentialing, enrollment, and provider monitoring workflows for healthcare payers.

4 investors

Verisian builds software for clinical research and public health authorities to analyze and monitor clinical trial data in real-time, improving decision-making and trial safety. The platform addresses limitations in traditional CDISC standardization by streamlining analysis and submission cycles.

4 investors

Vesteck develops medical device technology in the cardiovascular/endovascular space. The investors page presents an investor presentation and a section on the company's backers but does not name specific individuals or firms.

4 investors

Vi's Data Web is a data platform for health enterprises that integrates physiographic, demographic, usage, and licensed partner data into an AI-ready layer covering over 190 million de-identified patient records across 96% of U.S. households. It applies proprietary predictive models and LLMs to support behavior prediction, targeting, patient engagement, and operational optimization.

4 investors

Viage Therapeutics is a neuroscience drug developer working on novel oral neurotherapeutics that target the gut-brain axis, including its lead clinical candidate DGX-001 for cognitive impairment in conditions such as Alzheimer's and Parkinson's disease. Its pipeline includes neuropeptides and small molecules aimed at cognitive impairment, depression, anxiety, and inflammatory disease.

4 investors

Vico Therapeutics develops targeted genetic medicines for neurological disorders, with a focus on antisense oligonucleotide therapies designed to address the underlying genetic causes of diseases like Huntington's disease and spinocerebellar ataxias.

4 investors

Videa builds AI tools for dental clinicians to help identify, document, and communicate care while reducing operational burden in dental practices. The company applies artificial intelligence to dental diagnostics and care delivery to improve oral health at scale.

4 investors

Vim is a healthcare platform that embeds clinical tools and AI-powered applications directly into electronic health record (EHR) workflows, enabling care teams to take action without switching systems. The platform provides a marketplace for deploying health tech applications across multiple EHRs with built-in interoperability and compliance infrastructure.

4 investors

Vima Therapeutics is a biotech company developing drug treatments for movement disorders such as dystonia and related neurological diseases. It is run by a team of physicians, scientists, and drug-development specialists focused on neurological conditions.

4 investors

Violet provides healthcare organizations with data analytics and tools to measure and improve their ability to deliver person-centered care that considers patients' individual preferences, identities, and experiences. The company works with health systems and payers to identify gaps in care delivery and support ongoing improvement across patient populations.

4 investors